Phase II study of IRInotecan treatment after COmbined chemo‐immunotherapy for extensive‐stage small cell lung cancer: Protocol of IRICO study.

Autor: Tomono, Hiromi^1,2 (AUTHOR), Taniguchi, Hirokazu^1,3 (AUTHOR) hirokazu_pc@nagasaki-u.ac.jp, Fukuda, Minoru^3,4 (AUTHOR), Ikeda, Takaya² (AUTHOR), Nagashima, Seiji² (AUTHOR), Akagi, Kazumasa¹ (AUTHOR), Ono, Sawana¹ (AUTHOR), Umeyama, Yasuhiro¹ (AUTHOR), Shimada, Midori^1,5 (AUTHOR), Gyotoku, Hiroshi¹ (AUTHOR), Takemoto, Shinnosuke¹ (AUTHOR), Hisamatsu, Yasushi⁶ (AUTHOR), Morinaga, Ryotaro⁶ (AUTHOR), Tagawa, Ryuta⁷ (AUTHOR), Ogata, Ryosuke^1,7 (AUTHOR), Dotsu, Yosuke⁷ (AUTHOR), Senju, Hiroaki^7,8 (AUTHOR), Soda, Hiroshi⁷ (AUTHOR), Nakatomi, Katsumi⁹ (AUTHOR), Hayashi, Fumiko⁴ (AUTHOR)

Publikováno v: Thoracic Cancer. Oct2023, Vol. 14 Issue 28, p2890-2894. 5p.